Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain

Overview

Journal Front Neurosci

Date 2018 Apr 18

PMID 29662433

Citations 14

Authors

Maria I Herrera

Lucas D Udovin

Nicolas Toro-Urrego

Carlos F Kusnier

Juan P Luaces

Francisco Capani

Affiliations

Soon will be listed here.

Abstract

Perinatal asphyxia (PA) is an obstetric complication associated with an impaired gas exchange. This health problem continues to be a determinant of neonatal mortality and neurodevelopmental disorders. Palmitoylethanolamide (PEA) has exerted neuroprotection in several models of brain injury and neurodegeneration. We aimed at evaluating the potential neuroprotective role of PEA in an experimental model, which induces PA in the immature rat brain. PA was induced by placing newborn rats in a water bath at 37°C for 19 min. Once their physiological conditions improved, they were given to surrogate mothers that had delivered normally within the last 24 h. The control group was represented by non-fostered vaginally delivered pups, mimicking the clinical situation. Treatment with PEA (10 mg/kg) was administered within the first hour of life. Modifications in the hippocampus were analyzed with conventional electron microscopy, immunohistochemistry (for NeuN, pNF-H/M, MAP-2, and GFAP) and western blot (for pNF H/M, MAP-2, and GFAP). Behavior was also studied throughout Open Field (OF) Test, Passive Avoidance (PA) Task and Elevated Plus Maze (EPM) Test. After 1 month of the PA insult, we observed neuronal nucleus degeneration in CA1 using electron microscopy. Immunohistochemistry revealed a significant increase in pNF-H/M and decrease in MAP-2 in CA1 reactive area. These changes were also observed when analyzing the level of expression of these markers by western blot. Vertical exploration impairments and anxiety-related behaviors were encountered in the OF and EPM tests. PEA treatment attenuated PA-induced hippocampal damage and its corresponding behavioral alterations. These results contribute to the elucidation of PEA neuroprotective role after PA and the future establishment of therapeutic strategies for the developing brain.

Citing Articles

Raloxifene Protects Oxygen-Glucose-Deprived Astrocyte Cells Used to Mimic Hypoxic-Ischemic Brain Injury.

Toro-Urrego N, Luaces J, Kobiec T, Udovin L, Bordet S, Otero-Losada M Int J Mol Sci. 2024; 25(22).

PMID: 39596189 PMC: 11594051. DOI: 10.3390/ijms252212121.

Lasting mesothalamic dopamine imbalance and altered exploratory behavior in rats after a mild neonatal hypoxic event.

Nikolic B, Trnski-Levak S, Kosic K, Drlje M, Banovac I, Hranilovic D Front Integr Neurosci. 2024; 17:1304338.

PMID: 38304737 PMC: 10832065. DOI: 10.3389/fnint.2023.1304338.

Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective.

Bordet S, Luaces J, Herrera M, Gonzalez L, Kobiec T, Perez-Lloret S Front Neurosci. 2023; 17:1215041.

PMID: 37650104 PMC: 10463751. DOI: 10.3389/fnins.2023.1215041.

Palmitoylethanolamide attenuates neurodevelopmental delay and early hippocampal damage following perinatal asphyxia in rats.

Herrera M, Udovin L, Kobiec T, Toro-Urrego N, Kusnier C, Kolliker-Frers R Front Behav Neurosci. 2022; 16:953157.

PMID: 36090655 PMC: 9452789. DOI: 10.3389/fnbeh.2022.953157.

The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice.

Cristiano C, Avagliano C, Cuozzo M, Liguori F, Calignano A, Russo R Biomolecules. 2022; 12(8).

PMID: 36009049 PMC: 9406031. DOI: 10.3390/biom12081155.

References

Lever C, Burton S, OKeefe J . Rearing on hind legs, environmental novelty, and the hippocampal formation. Rev Neurosci. 2006; 17(1-2):111-33. DOI: 10.1515/revneuro.2006.17.1-2.111. View

Lambert D, Vandevoorde S, Diependaele G, Govaerts S, Robert A . Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice. Epilepsia. 2001; 42(3):321-7. DOI: 10.1046/j.1528-1157.2001.41499.x. View

Ennaceur A, Delacour J . A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res. 1988; 31(1):47-59. DOI: 10.1016/0166-4328(88)90157-x. View

Matesic D, Lin R . Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J Neurochem. 1994; 63(3):1012-20. DOI: 10.1046/j.1471-4159.1994.63031012.x. View

Schieve L, Tian L, Baio J, Rankin K, Rosenberg D, Wiggins L . Population attributable fractions for three perinatal risk factors for autism spectrum disorders, 2002 and 2008 autism and developmental disabilities monitoring network. Ann Epidemiol. 2014; 24(4):260-6. PMC: 4562459. DOI: 10.1016/j.annepidem.2013.12.014. View

Sayd A, Anton M, Alen F, Caso J, Pavon J, Leza J . Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats. Int J Neuropsychopharmacol. 2014; 18(6). PMC: 4438549. DOI: 10.1093/ijnp/pyu111. View

Herrera-Marschitz M, Morales P, Leyton L, Bustamante D, Klawitter V, Espina-Marchant P . Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins. Neurotox Res. 2010; 19(4):603-27. PMC: 3291837. DOI: 10.1007/s12640-010-9208-9. View

Robertson C, Puskar A, Hoffman G, Murphy A, Saraswati M, Fiskum G . Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats. Exp Neurol. 2005; 197(1):235-43. DOI: 10.1016/j.expneurol.2005.09.014. View

Scuderi C, Valenza M, Stecca C, Esposito G, Carratu M, Steardo L . Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α. J Neuroinflammation. 2012; 9:49. PMC: 3315437. DOI: 10.1186/1742-2094-9-49. View

10.

Rivera P, Bindila L, Pastor A, Perez-Martin M, Pavon F, Serrano A . Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context. Front Cell Neurosci. 2015; 9:98. PMC: 4375993. DOI: 10.3389/fncel.2015.00098. View

11.

Pulsinelli W . Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res. 1985; 63:29-37. DOI: 10.1016/S0079-6123(08)61973-1. View

12.

Coppola M, Mondola R . Palmitoylethanolamide: from endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence. Med Hypotheses. 2013; 81(4):619-22. DOI: 10.1016/j.mehy.2013.07.016. View

13.

Sheerin A, Zhang X, Saucier D, Corcoran M . Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid. Epilepsia. 2004; 45(10):1184-8. DOI: 10.1111/j.0013-9580.2004.16604.x. View

14.

Koch M, Kreutz S, Bottger C, Benz A, Maronde E, Ghadban C . Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α. Neurotox Res. 2010; 19(2):330-40. DOI: 10.1007/s12640-010-9166-2. View

15.

Petrosino S, Iuvone T, Di Marzo V . N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities. Biochimie. 2010; 92(6):724-7. DOI: 10.1016/j.biochi.2010.01.006. View

16.

JOHNSON G, Jope R . The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration. J Neurosci Res. 1992; 33(4):505-12. DOI: 10.1002/jnr.490330402. View

17.

Bjelke B, Andersson K, Ogren S, Bolme P . Asphyctic lesion: proliferation of tyrosine hydroxylase-immunoreactive nerve cell bodies in the rat substantia nigra and functional changes in dopamine neurotransmission. Brain Res. 1991; 543(1):1-9. DOI: 10.1016/0006-8993(91)91041-x. View

18.

Ahmad A, Genovese T, Impellizzeri D, Crupi R, Velardi E, Marino A . Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats. Brain Res. 2012; 1477:45-58. DOI: 10.1016/j.brainres.2012.08.006. View

19.

Rojas D, Smith J, Benkers T, Camou S, Reite M, Rogers S . Hippocampus and amygdala volumes in parents of children with autistic disorder. Am J Psychiatry. 2004; 161(11):2038-44. DOI: 10.1176/appi.ajp.161.11.2038. View

20.

Fidaleo M, Fanelli F, Ceru M, Moreno S . Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands. Curr Med Chem. 2014; 21(24):2803-21. DOI: 10.2174/0929867321666140303143455. View